$CDNS · Cadence Design Systems, Inc.

Tech / Semis (EDA)NDX100
EPS 0–0
DIR 0–0
MAE

Latest call · 2026-04-24

⏳ Awaiting result · earnings 2026-04-27 AMC

The call

EPS
$1.95
BEAT· +2.1% vs street
Direction
🟢 UP
1d +2.5% · 3d +4.0%
Confidence
MEDIUM
Positioning: hype_neutral
Spot at call
$314.33
as of 2026-04-24

Head-to-head · Claude vs the Street vs reality

Claude Street Actual
EPS $1.95 $1.91 ⏳ pending
Revenue $1.47B $1.45B
Direction (1d) 🟢 UP 🟢 UP
15B · 7H · 1S
1d move +2.5%
3d move +4.0%

Thesis

Cadence enters the print de-risked after yesterday's -5.2% pre-earnings sell-off, with 67% of FY26 revenue already in a record $7.8B backlog and Synopsys just printing a clean beat+raise in the same TAM in mid-March. The ChipStack AI Super Agent launched in February is the under-modeled monetization vector, and the TSM capex guide-up tells you the wafer-starts backdrop for EDA is structurally accelerating.

What would flip it

A China-tariff warning or second-half hardware-demand guide-down would override the Q1 beat and take the multiple back toward the 52-week low.

💡 Pre-print de-risk + AI-semis read-through. Long into print, add on a clean guide-tighten.

The market's narrative

Cadence is the quieter of the two EDA compounders (vs SNPS) — Street models AI-accelerated chip-design demand, +16-17% Q1 revenue growth, and a 67%-of-FY backlog coverage entering 2026. The concern is second-half hardware demand visibility and the 12-13% China revenue concentration into an unresolved tariff backdrop.

Where the Street may be wrong

  • Yesterday's -5.21% move on 'analyst caution ahead of earnings' is pre-print de-risking, not a fundamental signal — short interest is still only 2.25% of float (no squeeze setup) but positioning is now leaner than it was a week ago. That's the hype_high → hype_neutral transition without a fundamental deterioration.
  • SNPS Q1 print in mid-March was a clean beat+raise on AI-accelerated design activity — Cadence sits in the exact same TAM with a ratable software model and 67% of FY26 revenue in backlog. The read-through is structurally supportive for both top-line and margin.
  • ChipStack AI Super Agent (launched Feb 2026) is the monetizable AI-native product angle that analyst models are still underweighting — bookings contribution in Q1 is the under-modeled surprise vector.

Peer read: SNPS Q1 beat-and-raise in mid-March on agentic AI design demand is the cleanest peer read. TSM's Q1 capex guide-up (+15%) is direct positive read-through: more wafer start capex = more EDA seat licenses. ARM's record royalty print Thursday night is supportive for the whole semis-design stack.

Reasoning

  • Company Q1 guide is rev $1.42-1.46B and non-GAAP EPS $1.89-1.95; consensus sits at $1.91 EPS on $1.446B rev — mid-range of the guide. Ratable-software backlog visibility (67% of FY26 already booked) makes the upper end the likely print.
  • Per the INTC lesson (forward-guide blowout overrides priced-in sentiment on AI/semis), the real catalyst is the 2026 FY guide. Current guide is $5.9-6.0B rev; SNPS precedent + TSM capex read-through + ChipStack AI monetization all support a tightening to $5.95-6.05B or better.
  • Stock is re-priced -5.2% as of yesterday's close, back to the low end of its recent trading range — unlike INTC (+74% YTD at print), CDNS enters de-risked. Hype_high framework doesn't apply the same way after this pre-print sell-off.
  • Buy/Hold/Sell mix 15/7/1 with Needham at $400 and Rosenblatt reiterating Buy = constructive analyst setup. Avg PT $355 vs spot $314 = +13% upside to consensus.
  • China commentary is the wildcard: management guided 12-13% of rev flat in 2026 vs 2025. A reiteration of flat-China + no tariff step-up = positive reaction; any incremental cautionary tone = reaction faded.

Risks to the call

  • Management pulls FY26 revenue guide down on second-half hardware/China visibility — hype_neutral-but-just-repriced stock gives back another -3-5% even on a headline Q1 beat.
  • Any explicit tariff-related commentary on China EDA export licensing would dominate the tape and send the multiple back toward the 52-week low of $262.